Navigation Links
Biomedical research gets its head into cloud computing
Date:8/17/2011

COLUMBUS, Ohio -- As cloud computing becomes the next big consumer techo trend, allowing people to access but not have to physically store everything from playlists to photos, it's also on the verge of revolutionizing the way research is done. Using the cloud model as inspiration, biomedical informatics scientists at The Ohio State University have created the Translational Research Informatics and Data management grid (TRIAD), a system which is helping researchers around the world access and analyze biomedical data at an unprecedented pace.

"With the current technology, a researcher might dedicate more than 100 hours to connect the dots between a set of tissue samples, the individual medical histories for the patients who provided those tissues, and then analyzing the group as a whole. With the TRIAD platform, researchers can now execute this type of search and analysis in minutes," says Philip R. O. Payne, chair of the department of biomedical informatics at The Ohio State University Medical Center.

The development of TRIAD started a year ago when a team led by Payne and Dr. Rebecca Jackson, principal investigator of Ohio State's Clinical and Translational Science Award, received funding from the National Institutes of Health to build a new system to meet the growing and unique needs of translational researchers. TRIAD has been so revolutionary for the biomedical informatics field, that the research team recently received an additional $300,000 in funding to complete the grant's specific aims and help extend and support its implementation at other academic research institutions.

How it Works

Cloud computing is a term used to describe a system that allows easy access to a shared pool of resources (e.g., applications, servers, storage, networks) that can be quickly allocated and released with minimal effort by an administrator. The "cloud" acts like a virtual supercomputer that can pull together a cluster of other computers
'/>"/>

Contact: David Crawford
crawford.1@osu.edu
614-293-3737
Ohio State University Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Improved method for capturing proteins holds promise for biomedical research
2. Glycans enter mainstream of biomedical science
3. Promising developments in vaccine research, development of a vaginal gel and PrEP lead to calls for a combination of biomedical and non biomedical approaches to HIV prevention policy
4. Geneticist receives Excellence in Science Award from coalition of biomedical researchers
5. Branch offices: New family of gold-based nanoparticles could serve as biomedical testbed
6. U.S. Biomedical Leaders Present a New National Device Innovation Strategy Based on "Value-driven Engineering"
7. Top Latin-American scientists named 2011 Pew Fellows in the Biomedical Sciences
8. 22 of Americas most promising scientists selected as 2011 Pew Scholars in the Biomedical Sciences
9. Stevens biomedical engineering students fight hypothermia on the battlefield
10. Tufts biomedical engineer Fiorenzo Omenetto named Guggenheim Fellow
11. Brigham and Womens Hospital researcher named National Space Biomedical Research Institute Fellow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 16, 2014 Research and Markets ... the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend ... for medical sensors in biomedical applications. Chemical sensors ... and correct diagnosis during surgical procedures. The Global ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays a ... while. Hypertension – the medical term for high blood pressure ... 1800s, and the inflatable cuff that,s used in measuring blood ... mean there,s nothing new about hypertension, its triggers and its ... about the condition and the best ways to treat it. ...
(Date:12/10/2014)... 9, 2014 CIE San Diego has launched ... the connective tissue that enhances care coordination among social ... share client-level information; earned a second $1 million grant ... serving seniors aging in community and; will be recognized ... 11 th 4-6p. CIE San Diego ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... Atlantic salmon species will have its genome fully ... funding agencies and industry from Canada, Chile and ... Chilean Economic Development Agency, InnovaChile, Norwegian Research Council, ... form the International Cooperation to Sequence the Atlantic ...
... This release is available in German and ... Aconcagua Mountain in the Andes is polluted with PCBs. An ... carcinogenic chlorine compounds in samples taken from America,s highest mountain. ... are among the highest traces found anywhere in the world ...
... Norm for exhaust emissions went into force for all ... (TUM) have demonstrated an engine that is already close ... A research team headed by Prof. Georg Wachtmeister from ... reducing the pollutants in exhaust emissions to barely measurable ...
Cached Biology News:Genome BC collaborates with Chile and Norway to sequence salmon genome 2White, but not pure 2White, but not pure 3Munich lab demonstrates diesel truck engine with barely measurable emissions 2Munich lab demonstrates diesel truck engine with barely measurable emissions 3
(Date:12/17/2014)... Xeno Diagnostics has again received an ... COLA inspection. Xeno has met all criteria for ... organization. Accreditation is earned only by laboratories that ... demonstrate continued accuracy in the performance of proficiency ... , While the Laboratory Excellence award ...
(Date:12/17/2014)... ROCKVILLE, Md. , Dec. 17, 2014 ... biopharmaceutical company dedicated to the acquisition, development and commercialization ... needs for the global market with a primary commercial ... that it has been granted a Type C meeting ... that the meeting will be held in February 2015.  ...
(Date:12/15/2014)... , Dec. 15, 2014 Organovo Holdings, ... company focused on delivering breakthrough 3D bioprinting technology,  ... and collaborators of its exVive3D TM Human ... available in full commercial release on November 18, ... resulting in several awards for innovation. ...
(Date:12/13/2014)... , Dec. 12, 2014 /CNW/ - MaRS and Virgin Unite ... that they have joined forces to support Canadian entrepreneurs tackling ... Virgin Group Founder was at the MaRS Centre to announce ... national impact venture fund. This fund has $1 million in ... Vancouver -based Mindset Social Innovation Foundation, founded by ...
Breaking Biology Technology:Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3MaRS and Virgin Unite partner to invest in business as a force for good 2MaRS and Virgin Unite partner to invest in business as a force for good 3
... 7, 2012 Innovative technology, local product advancements and ... business, Pioneer Hi-Bred, for continued growth, Pioneer President ... Sachs Agricultural Biotech Forum today. "Global trends ... developing economies are driving the demand for food and ...
... 7, 2012 Karyopharm Therapeutics Inc., a leader in ... presentations covering its Selective Inhibitors of Nuclear Export (SINE), ... on March 31 – April 4, 2012, in Chicago.  ... the use of Karyopharm,s novel SINE, along with Karyopharm ...
... N.J., March 6, 2012   Proteonomix, Inc. (OTC/BB: ... agreements with certain institutional investors, pursuant to which the ... E convertible preferred stock at an aggregate purchase price ... total of  895,291 shares of Proteonomix common stock) and ...
Cached Biology Technology:DuPont Leader Overviews 2012 Seed Research Pipeline with Investors 2DuPont Leader Overviews 2012 Seed Research Pipeline with Investors 3Karyopharm Therapeutics Announces Multiple Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid and Hematologic Malignancy Models and Spontaneous Canine Cancers at the American Association of Cancer Research (AACR) Meeting 2Karyopharm Therapeutics Announces Multiple Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid and Hematologic Malignancy Models and Spontaneous Canine Cancers at the American Association of Cancer Research (AACR) Meeting 3Proteonomix Announces a Private Placement of $3.8 Million 2Proteonomix Announces a Private Placement of $3.8 Million 3Proteonomix Announces a Private Placement of $3.8 Million 4
... This monoclonal antibody recognizes 30% ... unrelated individuals. It does not ... proteins lacking rheumatoid factor nor with ... be used in ELISA to detect ...
... Human IgG Fd. ELISA Specificity: (4) ,human IgG subclass 1 ... 100% ,human IgG subclass 3 100% ,human IgG ... ... 0.04% ,human IgG Fab ...
...
Human VEGF R2 (KDR) MAb (Clone 89106)...
Biology Products: